Microsatellite instability occurs in defined subsets of patients with acute myeloblastic leukaemia

被引:45
作者
Das-Gupta, EP [1 ]
Seedhouse, CH [1 ]
Russell, NH [1 ]
机构
[1] Univ Nottingham, Dept Clin Lab Sci, Div Haematol, Nottingham NG7 2RD, England
关键词
acute myeloblastic leukaemia; microsatellite instability; mismatch repair; mutator phenotype; cytogenetics;
D O I
10.1046/j.1365-2141.2001.02920.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Using a sensitive fluorescent-polymerase chain reaction technique we looked for microsatellite instability (MSI) as functional evidence of mismatch repair defects in 71 cases of acute myeloblastic leukaemia (AML). MSI was assessed at 11 loci in matched leukaemic and constitutional DNA. Nine out of 71 patients (13%) were found to have MSI. Four of these patients had therapy-related leukaemia and the remaining five were all over the age of 60 years. There was a high incidence of adverse-risk cytogenetics in the patients with MSI, including abnormalities of chromosomes 5 and/or 7. Of the nine cases of t-AML included in this study, four (44%) had MSI. MSI was also seen in five of 51 cases (10%) over the age of 60 years but not in any cases under the age of 60 years with de novo AML. Using a sensitive assay, our results suggest that MSI occurs in two subgroups of patients with AML: those with t-AML and the elderly (> 60 years), but is rare in younger patients.
引用
收藏
页码:307 / 312
页数:6
相关论文
共 28 条
[1]  
BenYehuda D, 1996, BLOOD, V88, P4296
[2]  
Bocker T, 1997, CANCER RES, V57, P4739
[3]  
Boland CR, 1998, CANCER RES, V58, P5248
[4]   Stability of microsatellites in myeloid neoplasias [J].
Boyer, JC ;
Risinger, JI ;
Farber, RA .
CANCER GENETICS AND CYTOGENETICS, 1998, 106 (01) :54-61
[5]   DNA MISMATCH REPAIR AND CANCER [J].
CHUNG, DC ;
RUSTGI, AK .
GASTROENTEROLOGY, 1995, 109 (05) :1685-1699
[6]  
Dietmaier W, 1997, CANCER RES, V57, P4749
[7]   The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial [J].
Grimwade, D ;
Walker, H ;
Oliver, F ;
Wheatley, K ;
Harrison, C ;
Harrison, G ;
Rees, J ;
Hann, I ;
Stevens, R ;
Burnett, A ;
Goldstone, A .
BLOOD, 1998, 92 (07) :2322-2333
[8]  
Hoang JM, 1997, CANCER RES, V57, P300
[9]  
Honma M, 2000, MOL CARCINOGEN, V28, P203, DOI 10.1002/1098-2744(200008)28:4<203::AID-MC3>3.0.CO
[10]  
2-1